Who is point Biopharma global?

Go to the homepage. POINT Biopharma Global, Inc. is a radiopharmaceutical company. It engages in the business of building a platform for the clinical development and commercialization of radioligands that fight cancer. The company was founded by Joe McCann and Neil E. Fleshner on April 15, 2020 and is headquartered in Indianapolis, IN.

Why did point Biopharma global (PNT) rise 80% in early trading?

Shares of POINT Biopharma Global (PNT) skyrocketed over 80% in early trading on Tuesday after Eli Lilly (LLY) agreed to buy the radiopharmaceutical firm for $1.4 billion to expand its cancer-fighting ...

What is the 12-month price forecast for point Biopharma?

The 12-month stock price forecast is $13.2, which is an increase of 4.27% from the latest price. NEW ORLEANS-- (BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of POINT Biopharma ...

Will Eli Lilly buy point Biopharma global?

Start With These S&P 500-Beating Lists Eli Lilly said Tuesday it will buy cancer specialist Point Biopharma Global for $1.4 billion, and PNT stock launched to a two-year high.